
About
Appointed to the Board 13 December 2016:Â Chair of Medical Science Committee. Member of the Nomination, Audit and Risk and Product and Services Innovation Committees.
Background:Â Over 20 years’ leadership experience as an academic physician/scientist across research, healthcare and medicine, and tertiary education. Co-Head of the Cancer Genetics Laboratory at the Kolling Institute for Medical Research and Chair of Research, North Sydney Local Health District. Former Dean, The University of Sydney’s Sydney Medical School and Head of Medicine at Sydney’s Royal North Shore Hospital.
Other boards:Â Director, MaynePharma, Ecofibre, EOF BIO LLC (associated with the Ecofibre directorship) and CS Pharmaceuticals Limited. Deputy Chairman (former Chairman), Hoc Mai Foundation. Senior Advisor to McKinsey & Company and Advisor to MinterEllison.
Former directorships:Â Chairman, National Health and Medical Research Council. Chairman, Medical Benefits Schedule Review Taskforce. Director, Lorica Health Pty Limited, Firefly and Digital Health Agency CRC, Woolcock Institute of Medical Research and QBiotics.
Personal Details
Qualifications & Experience
Other directorships (state)
(only entities turnover at least $5m p/a)
| Company | Committee | Position | Date Appointed |
|---|---|---|---|
![]() | Board | Member |
Working history
Committee/s
| Company | Committee | Role | Appointment Date | Resignation Date |
|---|---|---|---|---|
| Cochlear | Board | Member | 13/12/2016 | |
| Cochlear | Technology | Chairperson | 13/12/2016 | |
| Cochlear | Audit | Member | 13/12/2016 | |
| Cochlear | Risk & Compliance | Member | 13/12/2016 |
